REM-422: Clinical Trials

1 trial of REM-422, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Recruiting 1
Phase 21Recruiting 1

Follow REM-422: new trials by email Literature Review of REM-422 trials Research Report on REM-422

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of REM-422 in Patients With Recurrent, Metastatic, or Unresectable Adenoid Cystic Carcinoma
REM-422 - Adenoid Cystic Carcinoma, Metastatic Adenoid Cystic Carcinoma
Phase 1 / Phase 2RecruitingRemix Therapeutics1252023-12-202026-06-24

Conditions studied

Carcinoma, Adenoid Cystic (1)

Sponsors

Remix Therapeutics (1)

Countries

France (1)  ·  United States (1)

Top investigators

Mythili Koneru, MD, PhD (1)